Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3101
Kemper
KMPR
$2.05B
| $893K | ﹤0.01% |
35,733
+13,929
| +64% | +$387K |
2013 Q2
53 quarters
|
|
3102
SmartFinancial
SMBK
$821M
| $893K | ﹤0.01% |
18,007
+2,370
| +15% | +$120K |
2017 Q1
38 quarters
|
|
3103
The Greenbrier Companies
GBX
$1.32B
| $892K | ﹤0.01% |
22,266
+7,055
| +46% | +$325K |
2016 Q2
41 quarters
|
|
3104
Blue Bird Corp
BLBD
$1.96B
| $892K | ﹤0.01% |
16,067
+10,650
| +197% | +$719K |
2017 Q1
38 quarters
|
|
3105
CF Bankshares
CFBK
$239M
| $891K | ﹤0.01% |
26,280
+1,119
| +4% | +$38.5K |
2024 Q4
7 quarters
|
|
3106
Lennar Class B
LEN.B
$20B
| $891K | ﹤0.01% |
11,135
-5,082
| -31% | -$419K |
2015 Q2
45 quarters
|
|
3107
Jefferson Capital
JCAP
$1.15B
| $891K | ﹤0.01% |
46,674
+19,554
| +72% | +$401K |
2025 Q2
5 quarters
|
|
3108
Choiceone Financial
COFS
$547M
| $888K | ﹤0.01% |
27,489
+385
| +1% | +$12.9K |
2020 Q2
25 quarters
|
|
3109
Hovnanian Enterprises
HOV
$584M
| $886K | ﹤0.01% |
7,968
-1,310
| -14% | -$165K |
2013 Q2
53 quarters
|
|
3110
Willdan Group
WLDN
$1.06B
| $886K | ﹤0.01% |
11,988
-6,525
| -35% | -$516K |
2017 Q1
38 quarters
|
|
3111
National Vision
EYE
$1.43B
| $882K | ﹤0.01% |
53,858
+40,969
| +318% | +$777K |
2017 Q4
35 quarters
|
|
3112
Ultrapar
UGP
$5.79B
| $881K | ﹤0.01% |
120,371
+4,002
| +3% | +$26.4K |
2026 Q1
2 quarters
|
|
3113
Axogen
AXGN
$3.5B
| $880K | ﹤0.01% |
20,985
-37,429
| -64% | -$1.68M |
2017 Q1
38 quarters
|
|
3114
Varex Imaging
VREX
$781M
| $879K | ﹤0.01% |
47,649
+6,931
| +17% | +$106K |
2017 Q1
38 quarters
|
|
3115
TriCo Bancshares
TCBK
$1.66B
| $877K | ﹤0.01% |
17,139
+4,220
| +33% | +$235K |
2016 Q1
42 quarters
|
|
3116
Interface
TILE
$1.83B
| $877K | ﹤0.01% |
25,499
-9,206
| -27% | -$326K |
2016 Q1
42 quarters
|
|
3117
Silvia, Inc. Warrant
SVIAW
$4.63M
| $877K | ﹤0.01% |
2,192,868
-558,664
| -20% | -$170K |
2025 Q2
5 quarters
|
|
3118
Ingles Markets
IMKTA
$1.6B
| $877K | ﹤0.01% |
10,340
-172
| -2% | -$14.9K |
2015 Q4
43 quarters
|
|
3119
Epsilon Energy
EPSN
$160M
| $876K | ﹤0.01% |
151,092
+110,410
| +271% | +$637K |
2024 Q3
8 quarters
|
|
3120
Medical Properties Trust
MPT
$1.05B
| $876K | ﹤0.01% |
253,100
+18,502
| +8% | +$77.8K |
2013 Q2
53 quarters
|
|
3121
Radiant Logistics
RLGT
$458M
| $875K | ﹤0.01% |
100,716
+9,738
| +11% | +$85.2K |
2017 Q1
38 quarters
|
|
3122
MapLight Therapeutics
MPLT
$416M
| $874K | ﹤0.01% |
85,813
+72,838
| +561% | +$1.37M |
2025 Q4
3 quarters
|
|
3123
Maravai LifeSciences
MRVI
$1.15B
| $872K | ﹤0.01% |
113,895
+54,854
| +93% | +$379K |
2022 Q1
18 quarters
|
|
3124
USCB Financial Holdings
USCB
$368M
| $871K | ﹤0.01% |
39,890
+2,471
| +7% | +$54.4K |
2022 Q2
17 quarters
|
|
3125
Venture Global Inc
VG
$31.7B
| $870K | ﹤0.01% |
68,843
-911,923
| -93% | -$12.4M |
2025 Q2
5 quarters
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.